Aehr Test Systems (AEHR) Financials

Aehr Test Systems’ financial results show a sharp but uneven recovery in the latest quarter. Revenue increased to $18.8 million in Q4 fiscal 2026, up from $10.3 million in Q3 and $9.9 million in Q2. This was the company’s strongest quarterly revenue result since Q4 fiscal 2025, although it remained below the $20 million-plus quarterly levels reported in parts of fiscal 2024.

Profitability improved sequentially, but the improvement was not yet fully operational. Gross profit rose to $8.0 million, producing a gross margin of approximately 42.6%, compared with 32.7% in Q3. Operating expenses increased to $9.2 million, resulting in a $1.2 million operating loss. Aehr reported $1.4 million of net income, but this was primarily supported by a $1.8 million income-tax benefit despite a $455,000 pretax loss. Investors should therefore be cautious about treating Q4’s earnings as evidence of sustainable profitability.

The cash flow picture improved considerably in Q4. Operating cash flow turned positive at $1.8 million, compared with negative operating cash flow of $3.7 million in Q3 and $1.2 million in Q2. However, total cash increased by $79.4 million largely because Aehr issued $78.9 million of common equity. That financing strengthened liquidity but also introduces dilution risk and means the cash increase was not primarily generated by the business.

At the latest reported balance-sheet date, February 27, 2026, Aehr held $36.9 million in cash and equivalents against $18.3 million in total liabilities. Total equity was $138.8 million, and the company’s current ratio was approximately 11 times. The balance sheet appears well-capitalized, but inventory remained elevated at $41.2 million, more than three times quarterly revenue, creating potential risks if customer demand or product mix weakens.

• Revenue rebounded sharply in Q4 fiscal 2026 to $18.8 million from $10.3 million in Q3, indicating improved order activity or shipment timing.
• Gross margin improved to approximately 42.6% from 32.7% sequentially, suggesting better manufacturing absorption, pricing, or product mix.
• Operating cash flow turned positive at $1.8 million in Q4 after three consecutive quarters of negative operating cash flow.
• Liquidity is strong relative to reported obligations. The latest balance sheet showed $36.9 million of cash versus $18.3 million of total liabilities, with no material debt balance identified in the provided data.
• Capital expenditures have moderated. Q4 capital spending was $134,000, well below the $1.4 million reported in Q1 fiscal 2026 and $2.8 million in Q4 fiscal 2025.
• Q4 net income of $1.4 million was largely tax-driven. The company still posted a $1.2 million operating loss and a $455,000 pretax loss, so the quarter does not yet demonstrate recurring bottom-line profitability.
• Revenue remains volatile. Quarterly sales have ranged from $7.6 million to $22.3 million across the provided periods, making quarterly comparisons difficult and increasing the importance of multi-quarter demand trends.
• Aehr has recorded recurring operating and net losses. The company reported net losses in Q1 through Q3 fiscal 2026 and in most comparable quarters beginning in fiscal 2025.
• The large equity issuance may materially dilute shareholders. Q4 financing included $78.9 million from common-stock issuance, while weighted-average basic shares increased from 29.9 million in Q1 fiscal 2026 to 30.7 million in Q4.
• Inventory remains high. Net inventory was $41.2 million at the latest reported balance-sheet date, raising the possibility of slower turns, discounting, or future inventory charges if demand does not remain strong.

Overall, the latest quarter provides encouraging evidence of a revenue and gross-margin recovery, while the balance sheet offers substantial financial flexibility. Nevertheless, Aehr still needs to convert stronger sales into consistent operating profits and internally generated cash flow. Retail investors should also distinguish the company’s improved liquidity from its underlying performance, since the largest source of recent cash growth was equity financing rather than operations.